David B. Arciniegas, MD, was named recipient of the 2015 Mitchell Rosenthal Award for scientific and clinical achievement in the field of brain injury rehabilitation. The award will be presented at the 39th Annual Williamsburg Brain Injury Rehabilitation Conference to be held in April 2015. The Rosenthal Award was established in 2008 by the Traumatic Brain Injury Model Systems project directors in memory of Dr. Rosenthal as an inspiration to new generations of investigators.
The TIRR Memorial Hermann Pharmacy department is one of nine hospital pharmacies in the United States – and the only one in a rehabilitation hospital – chosen by the American Society of Health System Pharmacists to participate in an Antimicrobial Stewardship Mentored Impact Program. The selection process was competitive, with 110 proposals submitted. Carolyn Alessi, Pharm.D., and Susan Loughlin, Pharm.D., BCPS, submitted the proposal with the goal of expanding the hospital’s antimicrobial stewardship program to improve patient care, reduce rates of resistance, prevent antimicrobial-related toxicity, reduce the rate of readmissions to acute care hospitals and reduce the costs of inappropriate antimicrobial use and health care-associated infections.
David B. Arciniegas, MD, served as president of the International Brain Injury Association’s Tenth World Congress on Brain Injury held in San Francisco, March 19-23, 2014. During that meeting he was elected to a four-year term as chair of the International Brain Injury Association and began serving in that role at the conclusion of the conference.
Victor Chang, M.D., Allison Clark, PhD, Cindy Ivanhoe, M.D., Kacey Maestas, PhD, Angelle Sander, PhD, and Mark Sherer, PhD, APBB, FACRM, attended the 14th Annual Galveston Brain Injury Conference (GBIC), an invited forum that provides the opportunity for experts in the field of brain injury to come together for two days to discuss topics of importance to the care of individuals living with the effects of brain injury. A “think tank” that has convened annually since 2000, the GBIC is coordinated and sponsored by The University of Texas Medical Branch at Galveston School of Health Professions and the Transitional Learning Center of Galveston. The conference was held May 7-9, 2014.
Cindy B. Ivanhoe, MD, was invited to serve on the Clinical Education Committee for the upcoming International Toxin Association Meeting, to be held in January 2015 in Lisbon, Portugal. Dr. Ivanhoe is on the board of directors of the association.
Arciniegas DB, Frey KL, Anderson CA. Cessation of auditory verbal hallucinations after stroke in a patient with schizophrenia. Journal of Neuropsychiatry and Clinical Neurosciences. 2014;26(2):179-83 (P76).
Arciniegas DB, Nick T, Sander AM, Sherer M. Meta-analysis of the effects of acetylcholinesterase inhibitors on verbal memory deficits among persons with traumatic brain injury. Brain Injury. 2014;28(5-6):781.
Arciniegas DB, Sander A, Maestas K, Clark A, Sherer M. Hair cortisol: A potential biomarker of emotional distress among persons with traumatic brain injuries. Brain Injury. 2014;28(5-6):785.
Sander AM, Maestas KL, Arciniegas D, Clark A, Sherer M. Feasibility of acceptance and commitment therapy for treating emotional distress in persons with traumatic brain injury. Brain Injury. 2014;28(5-6):698.
Wortzel HS, Arciniegas DB. A heuristic for the clinical evaluation of traumatic brain injury and aggression. Journal of Neuropsychiatry and Clinical Neurosciences. 2014;26(2):179-83 (P79).
Wortzel HS, Arciniegas DB. The DSM-5 approach to the evaluation of traumatic brain injury and its neuropsychiatric sequelae. NeuroRehabilitation. 2014 May 12;[Epub ahead of print]. PMID: 24820171.
Arciniegas DB. Attention and Memory Impairments following Mild Traumatic Brain Injury: New Perspectives on an Old Problem. Invited Grand Rounds, Department of Psychiatry, University of Texas Health Science Center at San Antonio, April 2014.
Arciniegas DB, Nick TG, Sander A, Sherer M. Meta-analysis of the Effects of Acetylcholinesterase Inhibitors on Verbal Memory Deficits among Persons with Traumatic Brain Injury. Tenth World Congress on Brain Injury, International Brain Injury Association, San Francisco, March 2014.
Arciniegas DB (Chair), Silver JM (Co-chair), Kraus MF, McAllister TW. Neuropsychiatry of Traumatic Brain Injury. Invited Pre-meeting Workshop, Tenth World Congress on Brain Injury, International Brain Injury Association, San Francisco, March 2014, in which Dr. Arciniegas presented a lecture entitled “A Neuropsychiatric Approach to the Assessment of Persons with TBI during Inpatient Rehabilitation."
Arciniegas DB, Dams-O’Connor K. Screening for Cognitive Decline Among Persons with Moderate to Severe TBI in the Chronic Post-injury Period. Invited presentation summarizing the work of the Cognition Subgroup, Galveston Brain Injury Conference, Galveston, Texas, May 2014.
Ivanhoe CB. The Upper Motor Neuron Syndrome: Rehabilitation. Presented at the Baylor College of Medicine Comprehensive Review Course in Physical Medicine and Rehabilitation, Houston, March 2014.
Ivanhoe CB. Management of the Upper Motor Neuron Syndrome in Brain Injury. Invited presentation at the Alamo Head Injury Association Meeting, San Antonio, March 2014.
Li S. New Insights for Pathophysiology of Post-stroke Spasticity. Invited Grand Rounds, Department of PM&R, University of Pittsburgh, May 2014.
Goldberg TA, Pandya DA. Evaluation of Inpatient Pharmacist-managed Warfarin Dosing Protocol. Presented at the Texas Society of Health System Pharmacists Annual Seminar, Houston, April 2014.
Loughlin SM, Pandya DA. Carbidopa-Levodopa with Anticoagulants May Increase Risk of GI Bleed. Presented at the Texas Society of Health System Pharmacists Annual Seminar, Houston, April 2014.